Pharmanutra
Develops and distributes nutritional supplements and medical devices based on research.
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Manufacturing
Description
PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-05 12:58 |
PHARMANUTRA S.P.A.: PERFEZIONATO IL SECONDO CLOSING DELL’ACQUISIZIONE DI AKERN …
|
Italian | 184.0 KB | ||
| 2022-12-05 12:58 |
PHARMANUTRA S.P.A. COMPLETES AKERN S.R.L. ACQUISITION
|
English | 181.9 KB | ||
| 2022-11-15 19:20 |
PHARMANUTRA PARTNERS WITH THE LUNA ROSSA PRADA PIRELLI TEAM FOR THE 37th EDITIO…
|
English | 183.8 KB | ||
| 2022-11-15 19:19 |
PHARMANUTRA INSIEME A LUNA ROSSA PRADA PIRELLI TEAM PER LA 37^ EDIZIONE DELL’AM…
|
Italian | 184.3 KB | ||
| 2022-11-14 09:46 |
INTERIM FINANCIAL REPORT AS AT 30 SEPTEMBER 2022
|
English | 1.8 MB | ||
| 2022-11-14 09:34 |
PHN - RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2022
|
Italian | 2.0 MB | ||
| 2022-11-07 17:48 |
PR - BoD APPROVES INTERIM MANAGEMENT REPORT AS AT 30 SEPTEMBER 2022
|
English | 291.4 KB | ||
| 2022-11-07 17:46 |
CS - Il CdA approva il Resoconto Intermedio di gestione al 30 settembre 2022
|
Italian | 306.8 KB | ||
| 2022-09-15 19:17 |
PHARMANUTRA launches new Cetilar Oro and Apportal Vital
|
Italian | 181.2 KB | ||
| 2022-09-15 19:16 |
PHARMANUTRA_Lancio nuovi propdotti Cetilar Oro e Apportal Vital
|
Italian | 182.5 KB | ||
| 2022-09-14 16:07 |
PHARMANUTRA - H1 Financial Report as of 30 June 2022
|
English | 13.6 MB | ||
| 2022-09-14 16:05 |
PHARMANUTRA - Relazione Finanziaria Semestrale al 30 giugno 2022
|
Italian | 14.1 MB | ||
| 2022-09-14 15:18 |
PHARMANUTRA - Deposito della Relazione Finanziaria Semestrale al 30 giugno 2022
|
Italian | 171.6 KB | ||
| 2022-09-14 15:18 |
PR - Deposit of the Half-Year Financial Report as of 30 June 2022
|
English | 169.8 KB | ||
| 2022-09-05 17:51 |
PR - PHARMANUTRA - BOD approved the first half financial report as at 30 June 2…
|
English | 279.4 KB |
Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharmanutra
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharmanutra via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
